drugset / Trial / NCT06132191
Expanded Access Use of Cemiplimab in Patients With Solid Tumors
Summary
Provide expanded access of cemiplimab in patients with solid tumors
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cemiplimab | Monoclonal antibody | — | — |